Article | June 26, 2023

The Future Of eCOA And Wearable Devices

Source: TransPerfect
GettyImages-1363170016 wearables

Electronic Clinical Outcome Assessment (eCOA) wearables have revolutionized the collection of patient-reported data, enabling the handling of vast amounts of information in clinical research. As the volume and complexity of datasets continue to grow rapidly, the value of eCOAs becomes increasingly evident, offering innovative and convenient healthcare solutions for data collection and analysis. In 2022, the global eCOA solutions market was valued at $1.36 billion, and it is projected to maintain an annual growth rate of 15.2% from 2023 to 2030. Moreover, experts anticipate that wearable devices, particularly digital sensors, will be integrated into 70% of all clinical trials in the future.

With wearable devices becoming more advanced, user-friendly, and customizable to individual patient needs, there is significant potential to enhance patient engagement, compliance, and health outcomes. However, the next challenge for researchers lies in effectively collecting and managing these large datasets generated by the increased utilization of COA wearables.

Learn how by looking at the advantages of wearables and where they are headed in the future, manufacturers, providers, and researchers can better anticipate collaboration efforts to bridge the gaps in existing processes and maximize the potential of eCOA wearables in clinical research.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.

Subscribe to Clinical Tech Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Tech Leader